News for Immutep Limited (PRRUF)

Published at

Feb 11, 2025 5:55 PM

by insidermonkey.com

positive

positive

Is Immutep Limited (IMMP) the Best Long Term ASX Stock to Buy Now?

We recently compiled a list of the 10 Best Long Term ASX Stocks to Buy Now. In this article, we are going to take a look at where Immutep Limited (NASDAQ:IMMP) stands against the other long term ASX ...

PRRUF IMMP IMM.AX AND.AX

Read more →
Published at

Jan 31, 2025 2:18 PM

by manilatimes.net

positive

positive

Immutep Quarterly Activities Report Q2 FY25

**media[528993]**

PRRUF IMMP IMM.AX

Read more →
Published at

Jan 31, 2025 1:30 PM

by insidermonkey.com

mixed

mixed

Is Immutep Limited (IMMP) One of the Best ASX Stocks to Buy According to Hedge Funds?

We recently compiled a list of the 10 Best ASX Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Immutep Limited (NASDAQ:IMMP) stands against other best ASX...

MSCL.SN PRRUF IMMP IMM.AX

Read more →
Published at

Jan 28, 2025 10:37 PM

by seekingalpha.com

neutral

neutral

Immutep Limited: Continuing To Make The Case For Eftilagimod (NASDAQ:IMMP)

Immutep Limited (IMMP) is a promising biotech stock with a strong pipeline and solid financial foundation, making it a buy despite risks.

PRRUF IMMP IMM.AX

Read more →
Published at

Jan 27, 2025 12:18 AM

by insidermonkey.com

mixed

mixed

10 Best Australian Stocks to Buy Now

According to a report by Vanguard published on January 24, Australia's economy is expected to experience a gradual recovery in 2025, following its slowest growth in 32 years in 2024.

KZIA KZA.AX PRRUF IMMP IMM.AX

Read more →
Published at

Jan 22, 2025 2:16 PM

by manilatimes.net

mixed

mixed

Patient Enrolment Completed for EFTISARC-NEO Phase II Trial

**media[521487]**

MRKD.BA MRK.SN MRK.PA MRK.MX MRK 6MK.DE PRRUF NRC IMMP IMM.AX

Read more →
Published at

Jan 6, 2025 2:00 PM

by gurufocus.com

mixed

mixed

Patient Enrolment Completed for INSIGHT-003

Multi-centre trial evaluating efti in combination with pembrolizumab and chemotherapy in patients with non-small cell lung cancer reaches enrolment target of ap

MRKD.BA MRK.SN MRK.PA MRK.MX MRK 6MK.DE PRRUF IMMP IMM.AX

Read more →
Published at

Dec 16, 2024 2:00 PM

by gurufocus.com

positive

positive

Immutep and Monash University Announce First Publication Detailing How Human LAG-3 Binds to MHC Class II

Findings published in Science Immunology resolve how human LAG-3 binds to its main ligand providing a better foundation for development of blocking LAG-3 therap

PRRUF IMMP IMM.AX

Read more →
Published at

Dec 12, 2024 3:00 PM

by gurufocus.com

mixed

mixed

Immutep Reports Promising New Data in Head and Neck Cancer at ESMO Immuno-Oncology 2024

Data shows strong overall survival, progression-free survival, and durability from novel combination of efti in combination with pembrolizumab in difficult-to-t

PRRUF IMMP IMM.AX MRKD.BA MRK.SN MRK.PA MRK.MX MRK 6MK.DE

Read more →
Published at

Dec 12, 2024 2:32 PM

by manilatimes.net

mixed

mixed

Immutep Reports Promising New Data in Head and Neck Cancer at ESMO Immuno-Oncology 2024

**media[490451]**

PRRUF IMMP IMM.AX MRKD.BA MRK.SN MRK.PA MRK.MX MRK 6MK.DE

Read more →
Published at

Nov 15, 2024 9:18 PM

by seekingalpha.com

neutral

neutral

Immutep: Potential Of Efti As New Standard Of Care For NSCLC Patients (NASDAQ:IMMP)

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside with phase 3 and 2b trials ahead.

PRRUF IMMP IMM.AX

Read more →
Published at

Nov 14, 2024 2:37 PM

by manilatimes.net

mixed

mixed

Immutep's Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung Cancer

**media[466242]**

PRRUF IMMP IMM.AX MRKD.BA MRK.SN MRK.PA MRK.MX MRK 6MK.DE

Read more →
Published at

Nov 14, 2024 2:20 PM

by manilatimes.net

mixed

mixed

Positive Data from Phase II Trial in Soft Tissue Sarcoma Presented at CTOS 2024 Annual Meeting

**media[466206]**

PRRUF IMMP IMM.AX NRC

Read more →
Published at

Oct 2, 2024 7:00 PM

by globenewswire.com

mixed

mixed

SERD Market is Predicted to Exhibit Remarkable Growth Owing

The SERDs market is expected to grow significantly in the coming years. This is due to the increasing cancer diagnosis, high unmet need in ESR1 mutation...

PRRUF MRTX IMMP IMM.AX SHPMY SHPMF ARVN 4564.T 2607.HK

Read more →
Published at

Oct 1, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Breast Cancer Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The rising global incidence of breast cancer, driven by lifestyle changes and an aging population, is a key market driver. Technological advancements in...

PRRUF MRTX IMMP IMM.AX SHPMY SHPMF ARVN 4564.T 2607.HK

Read more →
Published at

Oct 1, 2024 11:30 AM

by globenewswire.com

mixed

mixed

Immune Checkpoint Inhibitors Market to hit USD 189.1 billion by 2032, says Global Market Insights Inc.

Immune checkpoint inhibitors industry is projected to witness a CAGR of 16.7% during the period 2024-2032. This growth can be attributed to ongoing...

ZEG.DE SHJBF REGN34.SA REGN.MX REGN PRRUF IMMP IMM.AX BGNEN.MX BGNE B1GN34.SA AZNN.MX AZNCF AZN.L AZN 688180.SS 6160.HK 1877.HK 0R2M.L 0A4J.L MRKD.BA MRK.SN MRK.PA MRK.MX MRK LLY.MX LLY.DE LLY.BA LLY LILY34.SA INCY I1NC34.SA GSK.L GSK GS7.DE GLAXF BRM.DE BMYB34.SA BMY.MX BMY.BA BMY 6MK.DE 0Q1G.L 0J9P.L

Read more →
Published at

Sep 16, 2024 3:42 PM

by benzinga.com

mixed

mixed

Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September - Dunxin Financial Hldgs (AMEX:DXF)

U.S. stocks traded mixed this morning, with the Dow Jones jumping over 200 points on Monday. Following the market opening Monday, the Dow traded up 0.54% to 41...

NCNA DXF DRMA BBLG PRRUF IMMP IMM.AX

Read more →
Published at

Sep 4, 2024 3:20 PM

by investing.com

positive

positive

Baird boosts Laboratory Corporation of America stock target, retains Outperform By Investing.com

Baird boosts Laboratory Corporation of America stock target, retains Outperform

PRRUF NVTA IMMP

Read more →
Published at

Jul 12, 2024 7:14 PM

by benzinga.com

mixed

mixed

Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session - ASP Isotopes (NASDAQ:ASPI)

Loading... Loading... Shares of ASP Isotopes Inc. ASPI fell during Friday's session after the company announced pricing of a $30 million public offering of 12 ...

YGMZ VSTM VRPX VMC.V TIL SXTC SNTG SANW QS-WT QS QLGN NISN LCID.MX FWRD EYPT EVGO BUSXF BUSXD BUS.V AZ.V AGRI AAZZF AAZZD 0LOV.L WFC KZIA KZA.AX BONY34.SA BK.MX BK BILIN.MX BILI B1IL34.SA 9626.HK 0HLQ.L TYHT PRRUF IMMP IMM.AX

Read more →
Published at

Jul 12, 2024 1:04 PM

by rttnews.com

mixed

mixed

Pre-market Movers: SNTG, SISI, IMMP, KZIA, ASPI…

China-based financial services business Sentage Holdings Inc. (SNTG) is up over 59 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

SNGXW SNGX KZIA KZA.AX 0A6I.L TKN.MX TK TIRX TIL SNTG PRRUF IZQVF INVVY INDV.L IMMP IMM.AX FORD DRMA ARRY TYHT SXTC OPENW OPEN1.MX OPEN

Read more →